ABO血型不合的异基因骨髓移植  被引量:31

ABO incompatible allogeneic bone marrow transplantation

在线阅读下载全文

作  者:许兰平[1] 郭乃榄[1] 汪素琴 刘开彦[1] 张耀臣 范蕴明 黄晓军[1] 陈欢 陆道培[1] 

机构地区:[1]北京医科大学人民医院血液病研究所,100044

出  处:《中华血液学杂志》1999年第8期413-415,共3页Chinese Journal of Hematology

摘  要:目的 探讨HLA 相合,ABO 血型不合的异基因骨髓移植(alloBMT) 中存在的免疫及造血问题。方法 对本所38 例ABO 血型主要不合,23 例次要不合的HLA 相合的alloBMT 受者进行分析,并选用同期ABO 血型相合的alloBMT 患者作配对比较。结果ABO 血型不合的alloBMT患者,输注骨髓后无一例发生急性溶血。经配对t 检验及χ2 检验,ABO 血型不合对骨髓植活、血小板恢复,GVHD 及5 年无病生存率均无影响; 在ABO 血型主要不合组, 红系开始恢复时间明显延迟,使红细胞输用量明显增多;其中5 例患者发生纯红细胞再生障碍( 纯红再障) ,持续约7 ~24 个月。发生纯红再障者均为“O”型血受者,红系恢复与血型抗体滴度具有相关性。结论ABO 血型不合可以进行alloBMT,但对发生纯红再障高危的患者宜慎重。Objective To explore the immunohematological problems in ABO incompatible allogeneic bone marrow transplantation (allo BMT). Methods Among 250 HLA matched allo BMTs, 61 were performed between ABO incompatible siblings. Out of these 61 BMTs, 38 were major ABO incompatible and 23, minor. Control group included 61 HLA matched Allo BMTs with ABO compatible grafts. The major ABO incompatible patients received marrow grafts depleted of erythrocytes by hydroxyethyl starch (HES) sedimentation. The minor or bidirectional received marrow grafts depleted of plasma to reduce anti A or anti B agglutinins. ABO antigen and antibody in the recipients sera were determined once a week. Results ABO incompatible grafts for BMT had no adverse effect on engraftment, recovery of platelets, incidence of GVHD or survival. No recipient developed clinically hemolysis during or after marrow infusion. In ABO major compatible group, the onset of erythropoiesis after BMT was delayed and more RBC transfusions were required. Five of 10 recipients with blood group “O' in this group developed pure red cell aplasia (PRCA), lasting 7~24 months. Two of them recovered without therapeutic intervention. In the PRCA patients, the RBC antibody titers remained high for a longer time after BMT than in those whose erythropoiesis reconstituted timely. Serious morbidity related to ABO incompatibility did not occur. Conclusion ABO incompatible allo BMT is fairly safe if there is indication, however, PRCA may develop in isolated cases.

关 键 词:骨髓移植 异基因 ABO血型不合 

分 类 号:R457.7[医药卫生—治疗学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象